Abstract
We report on the outcome of intravenous high-dose immunoglobulin (IVIg) treatment in four children with narcolepsy and cataplexy, in whom the early diagnosis and the extreme disease severity were indications for this potentially efficacious therapy. One of four patients showed an objective and persistent improvement in clinical features during and after IVIg treatment. Our data partially support the recent report of the efficacy of IVIg treatment in early diagnosed narcolepsy with cataplexy and support the need for a controlled multicenter clinical trial on IVIg in narcolepsy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Academy of Sleep Medicine (2005) International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester, Illinois
Arii J, Kanbayashi T, Tanabe Y, Sawaishi Y, Kimura S, Watanabe A, Mishima K, Hishikawa Y, Shimizu T, Nishino S (2004) CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders. Neurology 63:2440–2442
Boehmer LN, Wu MF, John J, Siegel JM (2004) Treatment with immunosuppressive and antiinflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severity diseases. Exp Neurol 188:292–299
Challamel MJ, Mazzola ME, Nevsimalova S, Cannard C, Louis J, Revol M (1994) Narcolepsy in children. Sleep 17:S17–S20
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240–1243
Dalakas MC (2004) Intravenous immunoglobulin in autoimmune neuromuscular diseases. JAMA 291:2367–2375
Dauvilliers Y, Carlander B, Rivier F, Touchon J, Tafti M (2004) Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol 56:905–908
Dauvilliers Y (2006) Follow-up of four narcolepsy patients treated with intravenous immunoglobulins. Ann Neurol 60:153
Dodel R, Peter H, Walbert T, Spottke A, Noelker C, Berger K, Siebert U, Oertel WH, Kesper K, Becker HF, Mayer G (2004) The socioeconomic impact of narcolepsy. Sleep 27:1123–1128
Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B (2003) The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep 26:455–458
Fronczek R, Verschuuren J, Lammers GJ (2007) Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy. J Neurol 254:1607–1608
Gerashchenko D, Murillo-Rodriguez E, Lin L, Xu M, Hallett L, Nishino S, Mignot E, Shiromani PJ (2003) Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp Neurol 184:1010–1016
Guy W (1976) Clinical Global Impression. ECDEU assessment manual for psychopharmacology, revised National Institute of Mental Health, Rockville, MD
Hecht M, Lin L, Kushida CA, Umetsu DT, Taheri S, Einen M, Mignot E (2003) Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Sleep 26:809–810
Kadouri A, Corruble E, Falissard B (2007) The improved Clinical Global Impression Scale (iCGI): development and validation in depression. BMC Psychiatry 7:7
Lecendreux M, Maret S, Bassetti C, Mouren MC, Tafti M (2003) Clinical efficacy of highdose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J Sleep Res 12:347–348
Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Daniel LL, Bailey D, Berry RB, Kapen S, Kramer M; Standards of Practice Committee of the American Academy of Sleep Medicine (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121
Serra L, Montagna P, Mignon E, Lugaresi E, Plazzi G (2008) Cataplexy features in childhood narcolepsy. Mov Disord 23:858–865
Smith AJ, Jackson MW, Neufing P, McEvoy RD, Gordon TP (2004) A functional autoantibody in narcolepsy. Lancet 364:2122–2124
Thannickal TC, Moore RY, Nienhuis R, Ramanathan L, Gulyani S, Aldrich M, Cornford M, Siegel JM (2000) Reduced number of hypocretin neurons in human narcolepsy. Neuron 27:469–474
Thannickal TC, Siegel JM, Nienhuis R, Moore RY (2003) Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy. Brain Pathol 13:340–351
The U.S. Xyrem Multicenter Study Group (2002) A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25:42–49
Tucci V, Stegagno L, Vandi S, Ferrillo F, Palomba D, Vignatelli L, Ferini-Strambi L, Montagna P, Plazzi G (2003) Emotional information processing in patients with narcolepsy: a psychophysiologic investigation. Sleep 26:558–564
Yoss RE, Daly DD (1960) Narcolepsy in children. Pediatrics 25:1025–1033
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Plazzi, G., Poli, F., Franceschini, C. et al. Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy. J Neurol 255, 1549–1554 (2008). https://doi.org/10.1007/s00415-008-0983-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-008-0983-7